Crossmark

Strategies for Avoiding Neglect of Opportunity Costs by Decision-Makers

Published Online: 2021-09-01

Published Print: 2022-01

Authors

Karnon, Jonathan https://orcid.org/0000-0003-3220-2099
Partington, Andrew

Afzali, Hossein
License Information

Text and Data Mining valid from 2021-09-01

Version of Record valid from 2021-09-01
More Information

Article History

Accepted: 17 August 2021

First Online: 1 September 2021

Declarations

:

: No sources of funding were used to prepare this article.

: Jonathan Karnon is a member of the economic sub-committee of the Pharmaceutical Benefits Advisory Committee in Australia. Hossein Afzali is a member of the evaluation sub-committee of the Medical Services Advisory Committee in Australia. Andrew Partington has no known conflicts of interest.

Free to read: This content has been made available to all.

Document is current